Features of the effector cells state in patients with pulmonary tuberculosis with hypersensitivity indications to anti-TB drugs
Journal Title: Туберкульоз, легеневі хвороби, ВІЛ-інфекція - Year 2019, Vol 0, Issue 1
Abstract
Treatment of tuberculosis in almost 50.0 % of patients leads to side effects. Objective — to evaluate of the state of effector cells in patients with pulmonary tuberculosis, depending on the presence of clinical manifestations of hypersensitivity to anti-TB drugs. Materials and methods. Clinical and immunological examination was performed in 38 patients with pulmonary tuberculosis, which were divided into two groups: 1 — with the presence of typical clinical manifestations of hypersensitivity to anti-TB drugs; 2 — without apparent clinical signs of hypersensitivity, the control group consisted of 30 donors of blood. The state of effector cells was evaluated according to T-cell, B-cell immunity and phagocyte cell status. Results and discussion. A comparative analysis of the status of effector cells in patients with tuberculosis in both groups revealed that patients in group 1 had a significantly higher percentage of leukocytes and lymphocytes in the blood, and a more pronounced tension of humoral immunity, manifested by high levels of Immunoglobulin E Class, small circulating immune complexes and high titer of anti-tuberculosis antibodies. Conclusions. The decrease in the phagocyte count of neutrophils and monocytes in the blood is an adverse factor that may accompany the formation of the anergy of these important cells for anti-tuberculosis protection. Markers of the presence of hypersensitivity to anti-tuberculosis drugs in patients with pulmonary tuberculosis may be elevated levels: IgE in the blood (3 times and above the control), small CIC (1.5 times and above control), accompanied by a high titre of anti-TB antibodies (at 6 times and above the control), indicating a predisposition to allergic reactions and in the presence of clinical symptoms of allergy requires appropriate correction of treatment.
Authors and Affiliations
O. M. Recalovа, O. R. Panasiukova, Yu. O. Matviyenko, N. I. Grabchenko, S. G. Yasir, M. B. Shingaevsky
Keywords
Related Articles
- EP ID EP605979
- DOI 10.30978/TB2019-1-34
- Views 69
- Downloads 0
Abstracts of a scientific-practical conference with international participation «Actual problems of treatment and prevention of tuberculosis» (May 16—17, 2018, Kyiv)
-
Modern state and prospects of diagnostics of lung diseases caused by nontuberculous mycobacteria
Nowadays, in the world, various patterns of phenotypic and genotypic diagnostics of M. tuberculosis and nontuberculous mycobacteria, which are the causative agents of mycobacteriosis, are being introduced into practice....
Improvement of endothelial function and external respiration in patients with comorbidity of hypertension and stage III chronic obstructive pulmonary disease, using nitric oxide donor — L-arginine
Objective — to improve the efficacy of pharmacotherapy for patients with comorbidity of arterial hypertension (AH) and stage III chronic obstructive pulmonary disease (COPD) (group C), using an exogenous nitric oxide don...
Severe cases of tuberculosis and improving the efficiency of treatment in the application of the standard schemes
Objective — was to analyze the prevalence of severe cases of tuberculosis and the situation of comorbidity with various variants of concomitant pathology, substantiation of ways of influence for increase of efficiency of...
Predictors of development of HIV-associated neurological diseases
Objective — to study the impact of demographic, epidemiological and genetic factors on the course of HIV infection and manifestation of neurological diseases. Materials and methods. The study involved 70 patients with t...